Brian Day, Ph.d
Dr. Day is a consultant and was appointed Chief Scientific Officer of Aeolus Pharmaceuticals in September 2004. Dr. Day received his PhD in Pharmacology and Toxicology from Purdue University in 1992 and did his post doctoral training at Duke University from 1992 to 1995. He has extensive training in both pharmacology and toxicology with over 18 years of experience. Since 1994 he has helped guide the design and synthesis of metalloporphyrins and has discovered a number of their novel activities in biological systems. Dr. Day has authored over a 100 original scientific publications and served as a consultant to biotechnology companies for over 16 years. He is an active member of a number of scientific societies including the American Chemical Society, American Thoracic Society, Society for Free Radicals in Biology and Medicine, and Society of Toxicology. Dr Day is on the editorial board of Biochemical Pharmacology and was a member of the NIH Lung Injury, Repair and Remodeling Study Section from 2005 to 2009. Dr. Day has been at National Jewish Health since 1997 where he is a Vice Chair and Professor of Medicine. He is one of the scientific co-founders of Aeolus Pharmaceuticals and an inventor on a majority of the catalytic antioxidant program’s patents.